Business Wire
http://www.ironwoodpharma.com
January 02, 2013 04:00 PM Eastern Daylight Time 

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2013 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time at the Westin St. Francis Hotel in San Francisco. The presentation will be followed by a question and answer session that will begin at approximately 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.

A live webcast of Ironwood’s presentation and the question and answer session will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood’s website for 14 days following the conference.

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Ironwood is located in Cambridge, Mass. To learn more, visit www.ironwoodpharma.com.

Contacts

Ironwood Pharmaceuticals, Inc.
Media Relations
Lisa Buffington, 617-374-5103
Vice President, Corporate Communications
lbuffington@ironwoodpharma.com
or
Investor Relations
Meredith Kaya, 617-374-5082
Associate Director, Investor Relations
mkaya@ironwoodpharma.com

Recent Stories

  • View Press Release
    Ironwood Pharmaceuticals Announces Partial Exercise of Underwriters’ Option in Public Offering of Common Stock
    June 04, 2013
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that the underwriters of its previously announced public offering of shares of Class A common stock ... more »
  • View Press Release
    Ironwood Pharmaceuticals Prices Public Offering of Common Stock
    May 21, 2013
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced the pricing of an underwritten public offering of 10,500,000 shares of its Class A common stock at a... more »
  • View Press Release
    Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock
    May 20, 2013
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced that it has commenced an underwritten public offering of 10,500,000 shares of its Class A common sto... more »
More Stories
RSS feed for Ironwood Pharmaceuticals, Inc.
http://www.ironwoodpharma.com

Release Versions

  • EON: Enhanced Online News

Company Information Center

Ironwood Pharmaceuticals, Inc. RSS feed for Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

Share

  • Facebook
  • Twitter
  • LinkedIn
  • Delicious
  • Reddit
  • StumbleUpon
  • Digg
  • MySpace
  • Newsvine
  • Google Bookmark
  • Yahoo! Bookmark
  • EmailEmail
Tweet
  • EmailEmail
All News
Business Wire

Site Navigation

  • Home
    • Home
    • Submit a Press Release
  • Services
    • Overview
    • Targeting
    • Distribution
    • Financial Disclosure
    • Measurement & Analytics
    • Event News Services
    • Media & Journalist Tools
  • News
    • All News
    • News with Multimedia
    • News by Industry
    • News by Subject
    • News by Language
    • Tradeshows & Events
    • Earnings & Conference Calls
  • Education
    • Overview
    • Sample Press Release
    • FAQ
    • Find Your News Online
    • How-to
    • Disclosure Resources
    • White Papers
  • About Us
    • Overview
    • Become a Member
    • Contact Us
    • Follow Us
    • Jobs
    • Business Wire Newsroom

Search

Advanced News Search
  • Log In
  • Sign Up

Follow Us

  • Twitter
  • LinkedIn

More from Business Wire

  • Blog
  • Apps
  • Canada
  • UK/Ireland
  • Deutschland
  • France
  • Italy
  • Japan
  • EON: Enhanced Online News
  • Tradeshownews.com
  • PYMNTS.com

Business Wire Information

  • Contact Us
  • Privacy Statement
  • Terms of Use
  • ©2013 Business Wire